Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 179,600
-3,900 (-2.13%)
Last updated: Oct 8, 2026, 3:00 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 41.03 trillion as of October 8, 2026. It is the 813th most valuable company in the world and the 16th biggest in South Korea. Its market cap has increased by 6.18% in one year.
Market Cap
41.03T
Enterprise Value
43.78T
Revenue
4.90T
Global Rank
Country Rank
#16 South Korea
PE Ratio
26.26
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 41.03T, an increase of 39,423.66%. That is a compound annual growth rate of 39.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 41.03T | 3.60% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.37T |
| ALTEOGEN | 16.78T |
| Samsung Epis Holdings | 8.46T |
| HLB Co., Ltd. | 6.07T |
| SK Biopharmaceuticals | 5.69T |
| SK bioscience | 2.87T |
| LigaChem Biosciences | 2.70T |
| ABL Bio | 2.69T |